IS5792A - Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur - Google Patents
Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirurInfo
- Publication number
- IS5792A IS5792A IS5792A IS5792A IS5792A IS 5792 A IS5792 A IS 5792A IS 5792 A IS5792 A IS 5792A IS 5792 A IS5792 A IS 5792A IS 5792 A IS5792 A IS 5792A
- Authority
- IS
- Iceland
- Prior art keywords
- flowered
- viruses
- alternate
- compounds
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/104,363 US6037369A (en) | 1998-06-25 | 1998-06-25 | Compounds obtained from salvia species having antiviral Activity |
PCT/US1999/014297 WO1999066942A1 (en) | 1998-06-25 | 1999-06-25 | Compounds obtained from salvia species having antiviral activity |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5792A true IS5792A (is) | 2000-12-22 |
Family
ID=22300096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5792A IS5792A (is) | 1998-06-25 | 2000-12-22 | Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur |
Country Status (18)
Country | Link |
---|---|
US (1) | US6037369A (is) |
EP (1) | EP1089747A1 (is) |
JP (1) | JP2002518455A (is) |
KR (1) | KR20010071580A (is) |
CN (1) | CN1312722A (is) |
AU (1) | AU740698B2 (is) |
BR (1) | BR9912218A (is) |
CA (1) | CA2335956A1 (is) |
CZ (1) | CZ20004858A3 (is) |
HU (1) | HUP0103398A2 (is) |
ID (1) | ID28792A (is) |
IL (1) | IL140483A0 (is) |
IS (1) | IS5792A (is) |
MX (1) | MXPA01000195A (is) |
NO (1) | NO20006631L (is) |
PL (1) | PL345086A1 (is) |
TR (1) | TR200100450T2 (is) |
WO (1) | WO1999066942A1 (is) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001505583A (ja) * | 1996-12-05 | 2001-04-24 | ジョージタウン ユニヴァーシティー | 抗ウイルス活性を有するサルビア種の抽出物 |
US6043276A (en) * | 1998-06-25 | 2000-03-28 | Georgetown University School Of Medicine | Compounds obtained from salvia species having antiviral activity |
WO2001085189A1 (de) * | 2000-05-05 | 2001-11-15 | Parsenn-Produkte Ag | Zubereitung zur topischen behandlung von durch virusinfektionen verursachten manifestationen |
SG98409A1 (en) * | 2000-06-21 | 2003-09-19 | Chi Chiang Yang | Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus |
JP2002020283A (ja) * | 2000-06-22 | 2002-01-23 | Yang Chi-Chiang | Hivおよびレトロウイルスに関連する障害の処置または予防のための薬学的組成物および組み合わせ |
KR20020005222A (ko) * | 2000-06-28 | 2002-01-17 | 치-치앙 양 | Hiv 또는 레트로바이러스에 관련된 질환의 치료 또는예방용 약학적 조성물 및 조합물 |
US7071227B2 (en) * | 2000-09-26 | 2006-07-04 | The Johns Hopkins University | Antiviral compositions and methods of use |
US20070027209A1 (en) * | 2005-08-01 | 2007-02-01 | Lee Hyun C | Prevention and treatment of atherosclerosis with lithospermate B |
WO2008117901A1 (en) * | 2007-03-28 | 2008-10-02 | Industry-Academic Cooperation Foundation, Yonsei University | A method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae |
US20120041062A1 (en) * | 2009-03-30 | 2012-02-16 | Tianjin Tasly Pharmaceutical Co., Ltd. | Compound of salvianolic acid l, preparation method and use thereof |
CN101919836A (zh) * | 2009-06-17 | 2010-12-22 | 山东绿叶天然药物研究开发有限公司 | 迷迭香酸的新用途 |
CN103054976B (zh) * | 2011-10-21 | 2014-09-24 | 上海中医药大学 | 一种治疗血小板减少症的中药组合物及其制备方法和应用 |
CN103845403B (zh) * | 2014-02-27 | 2016-10-05 | 河南大学 | 丹参配方颗粒在制备预防和治疗艾滋病脑病药物方面的应用 |
CN104974119B (zh) * | 2014-04-01 | 2018-10-19 | 中国科学院上海药物研究所 | 一种高纯度丹酚酸b镁及其制备方法 |
CN108042524A (zh) * | 2017-12-21 | 2018-05-18 | 南方医科大学 | 丹酚酸b及其结构类似物在制备抗hpv病毒感染药物中的应用 |
CN109771410B (zh) * | 2019-03-06 | 2020-11-24 | 湖北大学 | 紫草酸在制备抗乙肝病毒药物中的用途 |
CN109771407B (zh) * | 2019-03-29 | 2021-11-26 | 成都医学院 | 迷迭香酸在制备抑制水痘-带状疱疹病毒的药物中的用途 |
CN110922286B (zh) * | 2019-11-23 | 2022-08-16 | 上海化工研究院有限公司 | 一种非对称芳基取代富烯化合物及其制备方法与应用 |
JPWO2021221043A1 (is) * | 2020-04-30 | 2021-11-04 | ||
CN114712342B (zh) * | 2022-05-10 | 2023-04-21 | 湖北大学 | 紫草酸在制备抗流感病毒药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5178865A (en) * | 1990-06-19 | 1993-01-12 | Cedars-Sinai Medical Center | Chinese herbal extracts in the treatment of hiv related disease in vitro |
US5346695A (en) * | 1991-03-27 | 1994-09-13 | Tampa Bay Research Institute | Methods of inhibiting HIV replication in vitro using polymers of p-hydroxylated cinnamic acids |
JP2001505583A (ja) * | 1996-12-05 | 2001-04-24 | ジョージタウン ユニヴァーシティー | 抗ウイルス活性を有するサルビア種の抽出物 |
-
1998
- 1998-06-25 US US09/104,363 patent/US6037369A/en not_active Expired - Fee Related
-
1999
- 1999-06-25 WO PCT/US1999/014297 patent/WO1999066942A1/en not_active Application Discontinuation
- 1999-06-25 CZ CZ20004858A patent/CZ20004858A3/cs unknown
- 1999-06-25 PL PL99345086A patent/PL345086A1/xx unknown
- 1999-06-25 CA CA002335956A patent/CA2335956A1/en not_active Abandoned
- 1999-06-25 IL IL14048399A patent/IL140483A0/xx unknown
- 1999-06-25 EP EP99930658A patent/EP1089747A1/en not_active Withdrawn
- 1999-06-25 AU AU47149/99A patent/AU740698B2/en not_active Ceased
- 1999-06-25 TR TR2001/00450T patent/TR200100450T2/xx unknown
- 1999-06-25 BR BR9912218-9A patent/BR9912218A/pt not_active Application Discontinuation
- 1999-06-25 MX MXPA01000195A patent/MXPA01000195A/es not_active Application Discontinuation
- 1999-06-25 HU HU0103398A patent/HUP0103398A2/hu unknown
- 1999-06-25 ID IDW20002741A patent/ID28792A/id unknown
- 1999-06-25 KR KR1020007014664A patent/KR20010071580A/ko not_active Application Discontinuation
- 1999-06-25 JP JP2000555628A patent/JP2002518455A/ja active Pending
- 1999-06-25 CN CN99809677A patent/CN1312722A/zh active Pending
-
2000
- 2000-12-22 IS IS5792A patent/IS5792A/is unknown
- 2000-12-22 NO NO20006631A patent/NO20006631L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1312722A (zh) | 2001-09-12 |
WO1999066942A9 (en) | 2000-06-22 |
AU740698B2 (en) | 2001-11-15 |
CZ20004858A3 (cs) | 2001-09-12 |
NO20006631D0 (no) | 2000-12-22 |
TR200100450T2 (tr) | 2001-07-23 |
CA2335956A1 (en) | 1999-12-29 |
PL345086A1 (en) | 2001-12-03 |
MXPA01000195A (es) | 2002-04-24 |
BR9912218A (pt) | 2002-07-23 |
NO20006631L (no) | 2001-02-26 |
EP1089747A1 (en) | 2001-04-11 |
KR20010071580A (ko) | 2001-07-28 |
ID28792A (id) | 2001-07-05 |
JP2002518455A (ja) | 2002-06-25 |
IL140483A0 (en) | 2002-02-10 |
HUP0103398A2 (hu) | 2002-01-28 |
US6037369A (en) | 2000-03-14 |
WO1999066942A1 (en) | 1999-12-29 |
AU4714999A (en) | 2000-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5792A (is) | Aðferð til þess að vinna efnasambönd úr lyfjablómum af varablómaætt sem hafa neikvæða virkni á veirur | |
DK1296656T3 (da) | Fremgangsmåde til fremstilling af et præparat | |
DK1159274T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK0812845T3 (da) | Fremgangsmåde til fremstilling af sildenafil | |
DK1232152T3 (da) | Forbedret fremgangsmåde til fremstilling af nitrogensubstituerede aminotetraliner | |
DK1008577T4 (da) | Fremgangsmåde til fremstilling af methanol | |
DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
DK1309545T3 (da) | Fremgangsmåde til fremstilling af alkylarylsulfonater | |
DK0937055T3 (da) | Fremgangsmåde til fremstilling af d,I-alfa-tocopherol | |
FI20011622A (fi) | Menetelmä sitalopraamin valmistamiseksi | |
DK1349580T3 (da) | Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning | |
DK1199927T3 (da) | Fremgangsmåde til fremstilling af ammoniumglyphosatpulver | |
DK1958938T3 (da) | Fremgangsmåde til fremstilling af 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid | |
DK1028960T3 (da) | Fremgangsmåde til fremstilling af thiazolidinedion | |
DK1114664T3 (da) | Fremgangsmåde til separation af bestanddelene i en dispersion | |
DK1446107T3 (da) | Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin | |
DK1092243T3 (da) | Fremgangsmåde til fremstilling af en mikroporøs film | |
DK0973769T3 (da) | Fremgangsmåde til fremstilling af eprosartan | |
NO20000933D0 (no) | Fremgangsmåte for fremstilling av polymer | |
DK1298124T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
DK0971931T3 (da) | Fremgangsmåde itl debenzylering af dibenzylbiotin | |
DK0735043T3 (da) | Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran | |
DK1311494T3 (da) | Kontinuerlig fremgangsmåde til fremstilling af chlorthiazolpesticider |